Nothing written yet for this company.
Chabiotech Co., Ltd. (085660) was selected for a government backed cell and gene therapy quality research project.
| Period | 085660 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | -0.9% | -3.0% | +2.1% |
| 1 month | -14.8% | +4.2% | -19.0% |
| 3 months | -36.9% | -22.5% | -14.4% |
| 6 months | -53.2% | -16.9% | -36.3% |
| Year to date | -44.9% | -12.1% | -32.8% |
| 1 year | -24.5% | +1.0% | -25.5% |
Closed at 1% of the way from its 52-week low (₩7,920) to its 52-week high (₩23,850).
Chabiotech Co., Ltd. makes pharmaceutical ingredients in South Korea. It is listed on KOSDAQ, was founded in 2002, is based in Seoul, and has revenue of a few trillion won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2002 |
| Korean name | 차바이오텍 | Head office | Seoul |
| Symbol | Last Price |
|---|---|
| 185750Chong Kun Dang Pharmaceutical Corp. | ₩68,000 -0.3% |
| 115180Qurient Co., Ltd. | ₩23,050 +17.3% |
| 476830Rznomics, Inc. | ₩28,200 +6.8% |
| 003850Boryung Corporation | ₩9,040 +1.6% |
| 950260Ingenia Therapeutics Inc.(reg.s) | ₩15,580 -1.5% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |
| 001060JW Pharmaceutical | ₩27,500 +1.3% |
| 456160G2GBIO, Inc. | ₩37,950 +5.7% |